Is measurement of D-dimer useful in the diagnosis of cerebral venous thrombosis?

被引:79
作者
Lalive, PH
de Moerloose, P
Lovblad, K
Sarasin, FP
Mermillod, B
Sztajzel, R
机构
[1] Univ Hosp Geneva, Dept Neurol, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland
[3] Univ Hosp Geneva, Dept Med & Surg Emergency, CH-1211 Geneva 14, Switzerland
[4] Univ Hosp Geneva, Dept Med Informat, CH-1211 Geneva 14, Switzerland
[5] Univ Hosp Geneva, Div Angiol & Haemostasis, CH-1211 Geneva 14, Switzerland
关键词
D O I
10.1212/01.WNL.0000090562.66120.1F
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The diagnosis of cerebral venous thrombosis (CVT) is a challenge because its clinical presentation is variable, brain CT may be normal, and MRI is not always available. Furthermore, early treatment may be effective. As D-dimer ( DD) measurement is a sensitive test for the exclusion of venous thromboembolism, the authors studied whether this test could be useful in the diagnosis of CVT. Methods: A prospective study of 54 consecutive patients with headaches suggestive of CVT was conducted between October 2000 and September 2002. DD levels were tested for all patients in the emergency room before brain CT or MRI was performed. Results: Twelve ( 22%) of the 54 patients had CVT, and 10 (83%) of these 12 patients had DD level of > 500 ng/mL ( sensitivity of 83% and negative predictive value of 95%). Two patients with confirmed CVT and DD of < 500 ng/mL had a history of chronic headache of > 30 days' duration. In the 42 patients without confirmed CVT, only 4 patients had DD level of < 500 ng/mL ( specificity of 90% and positive predictive value of 71%). Conclusions: DD test is useful in the diagnosis of acute CVT. A value below 500 ng/mL makes acute thrombosis unlikely.
引用
收藏
页码:1057 / 1060
页数:4
相关论文
共 26 条
[1]
DISEASE SEVERITY IN RHEUMATOID-ARTHRITIS - RELATIONSHIPS OF PLASMA TUMOR-NECROSIS-FACTOR-ALPHA, SOLUBLE INTERLEUKIN 2-RECEPTOR, SOLUBLE CD4/CD8 RATIO, NEOPTERIN, AND FIBRIN D-DIMER TO TRADITIONAL SEVERITY AND FUNCTIONAL MEASURES [J].
BECKHAM, JC ;
CALDWELL, DS ;
PETERSON, BL ;
PIPPEN, AMM ;
CURRIE, MS ;
KEEFE, FJ ;
WEINBERG, JB .
JOURNAL OF CLINICAL IMMUNOLOGY, 1992, 12 (05) :353-361
[2]
Ben Ren-Jy, 1999, Journal of Microbiology Immunology and Infection, V32, P57
[3]
Isolated intracranial hypertension as the only sign of cerebral venous thrombosis [J].
Biousse, V ;
Ameri, A ;
Bousser, MG .
NEUROLOGY, 1999, 53 (07) :1537-1542
[4]
BOUNAMEAUX H, 1994, THROMB HAEMOSTASIS, V71, P1
[5]
Cerebral venous thrombosis: diagnosis and management [J].
Bousser, MG .
JOURNAL OF NEUROLOGY, 2000, 247 (04) :252-258
[6]
CEREBRAL VENOUS THROMBOSIS - A REVIEW OF 38 CASES [J].
BOUSSER, MG ;
CHIRAS, J ;
BORIES, J ;
CASTAIGNE, P .
STROKE, 1985, 16 (02) :199-213
[7]
Cerebral venous thrombosis - Nothing, heparin, or local thrombolysis? [J].
Bousser, MG .
STROKE, 1999, 30 (03) :481-483
[8]
Brill-Edwards P, 1999, THROMB HAEMOSTASIS, V82, P688
[9]
CEREBRAL VENOUS THROMBOSIS ASSOCIATED WITH PREGNANCY AND PUERPERIUM - REVIEW OF 67 CASES [J].
CANTU, C ;
BARINAGARREMENTERIA, F .
STROKE, 1993, 24 (12) :1880-1884
[10]
TAFI antigen and D-dimer levels during normal pregnancy and at delivery [J].
Chabloz, P ;
Reber, G ;
Boehlen, F ;
Hohlfeld, P ;
de Moerloose, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (01) :150-152